🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hong Xiao

Fujian Medical University

ORCID: 0000-0002-0401-9222

Also affiliated with First Affiliated Hospital of Fujian Medical University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma”.

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002485

N/A

5.0DataRank · unranked

185 citations

Marka R. Crittenden, Kristina H. Young, Hong Xiao, Yaping Wu, Marcus Couey +11 more

Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck

Oral Oncology(2022)10.1016/j.oraloncology.2022.106183

N/A

0DataRank · unranked

11 citations

Austin K. Mattox, Daniel Clayburgh, Mihir R. Patel, R. Bryan Bell, Bevan Yueh +15 more

Complement as a major mediator of ANCA vasculitis and a target for precision therapy

Expert Review of Clinical Immunology(2024)10.1080/1744666x.2024.2405170

N/A

0DataRank · unranked

4 citations

Sarah E. Lewis, Hong Xiao, Peiqi Hu, J. Charles Jennette, Eveline Y. Wu +1 more